Yeruusaalem, 19 Nofembar, 2025 (TPS-IL) — Shirkadda Israa’iil ee tiknoolajiyada caafimaadka ee IceCure Medical Ltd. waxay heshay ogolaansho sharci ah oo ka timid Switzerland ee Nidaamkeeda ProSense Cryoablation, taasoo u suurtagalinaysa daawaynta burooyinka xun iyo kuwa wanaagsan ee naaska, sambabada, beerka, kelyaha, iyo nidaamka muruqyada iyo lafaha. Oggolaanshaha Swissmedic ayaa timid ka dib markii FDA ay dhawaan u ogolaatay nidaamka kansarka naaska ee khatarta yar ee Maraykanka.
Nidaamka IceCure ee aan aadka u qallafsanayn wuxuu isticmaalaa nitrogen-ka dareeraha ah si loo burburiyo burooyinka, taasoo yaraynaysa khatarta qaliinka isla markaana u suurtagalinaysa habraacyo lagu sameeyo xafiisyada bukaanada ku nool Yurub oo dhan.
Eyal Shamir, oo ah Madaxa Fulinta ee IceCure, ayaa sheegay in oggolaanshahaasi “uu kordhinayo dardargelinta ganacsigeena oo uu nagu soo dhoweynayo in ProSense uu noqdo habka caadiga ah ee daawaynta ee lagu beddelo qaliinka adduunka.